Year |
Citation |
Score |
2008 |
Rudat V, Eckel H, Volling P, Schröder M, Staar S, Wallner F, Wannenmacher M, Dietz A. Long-term results of a prospective multicenter phase II study to preserve the larynx function using concomitant boost radiochemotherapy with Carboplatin. Radiotherapy and Oncology. 89: 33-37. PMID 18621428 DOI: 10.1016/J.Radonc.2008.06.005 |
0.384 |
|
2005 |
Combs SE, Gutwein S, Schulz-Ertner D, Van Kampen M, Thilmann C, Edler L, Wannenmacher MM, Debus J. Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme: Phase I/II study Strahlentherapie Und Onkologie. 181: 372-377. PMID 15925979 DOI: 10.1007/s00066-005-1359-x |
0.355 |
|
2005 |
Milker-Zabel S, Zabel A, Schulz-Ertner D, Schlegel W, Wannenmacher M, Debus J. Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors. International Journal of Radiation Oncology Biology Physics. 61: 809-816. PMID 15708260 DOI: 10.1016/J.Ijrobp.2004.07.669 |
0.454 |
|
2005 |
Zabel A, Milker-Zabel S, Zuna I, Wannenmacher M, Debus J. External beam radiotherapy in the treatment of male breast carcinoma: patterns of failure in a single institute experience. Tumori. 91: 151-155. DOI: 10.1177/030089160509100209 |
0.344 |
|
2004 |
Treiber M, Lehnert T, Oertel S, Krempien R, Bischof M, Buechler M, Wannenmacher M, Debus J. Intraoperative radiotherapy--special focus: recurrent rectal carcinoma. Frontiers of Radiation Therapy and Oncology. 38: 52-56. PMID 15458187 DOI: 10.1159/000078264 |
0.347 |
|
2004 |
Milker-Zabel S, Zabel A, Huber P, Schlegel W, Wannenmacher M, Debus J. Stereotactic conformal radiotherapy in patients with growth hormone-secreting pituitary adenoma. International Journal of Radiation Oncology Biology Physics. 59: 1088-1096. PMID 15234043 DOI: 10.1016/J.Ijrobp.2003.12.012 |
0.43 |
|
2004 |
Fritz P, Stein U, Hasslacher C, Zierhut D, Wannenmacher M, Pritsch M. External beam radiotherapy fails to prevent restenosis after iliac or femoropopliteal percutaneous transluminal angioplasty: Results of a prospective randomized double-blind study International Journal of Radiation Oncology Biology Physics. 59: 815-821. PMID 15183485 DOI: 10.1016/J.Ijrobp.2003.11.036 |
0.387 |
|
2004 |
Fleckenstein K, Hof H, Lohr F, Wenz F, Wannenmacher M. Prognostic factors for brain metastases after whole brain radiotherapy. Data from a single institution. Strahlentherapie Und Onkologie : Organ Der Deutschen RöNtgengesellschaft ... [Et Al]. 180: 268-73. PMID 15127156 DOI: 10.1007/S00066-004-1234-1 |
0.303 |
|
2004 |
Zabel A, Milker-Zabel S, Huber P, Schulz-Ertner D, Schlegel W, Wannenmacher M, Debus J. Fractionated stereotactic conformal radiotherapy in the management of large chemodectomas of the skull base International Journal of Radiation Oncology Biology Physics. 58: 1445-1450. PMID 15050322 DOI: 10.1016/J.Ijrobp.2003.09.070 |
0.449 |
|
2004 |
Schulz-Ertner D, Nikoghosyan A, Thilmann C, Haberer T, Jäkel O, Karger C, Kraft G, Wannenmacher M, Debus J. Results Of Carbon Ion Radiotherapy In 152 Patients International Journal of Radiation Oncology Biology Physics. 58: 631-640. PMID 14751537 DOI: 10.1016/J.Ijrobp.2003.09.041 |
0.403 |
|
2004 |
Thilmann C, Sroka-Perez G, Krempien R, Hoess A, Wannenmacher M, Debus J. Inversely planned intensity modulated radiotherapy of the breast including the internal mammary chain: a plan comparison study. Technology in Cancer Research & Treatment. 3: 69-75. PMID 14750895 DOI: 10.1177/153303460400300108 |
0.415 |
|
2004 |
Münter MW, Karger CP, Hoffner SG, Hof H, Thilmann C, Rudat V, Nill S, Wannenmacher M, Debus J. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy. International Journal of Radiation Oncology Biology Physics. 58: 175-184. PMID 14697436 DOI: 10.1016/S0360-3016(03)01437-8 |
0.471 |
|
2004 |
Nikoghosyan A, Schulz-Ertner D, Didinger B, Jäkel O, Zuna I, Höss A, Wannenmacher M, Debus J. Evaluation of therapeutic potential of heavy ion therapy for patients with locally advanced prostate cancer. International Journal of Radiation Oncology Biology Physics. 58: 89-97. PMID 14697425 DOI: 10.1016/S0360-3016(03)01439-1 |
0.402 |
|
2003 |
Krempien RC, Daeuber S, Hensley FW, Wannenmacher M, Harms W. Image fusion of CT and MRI data enables improved target volume definition in 3D-brachytherapy treatment planning. Brachytherapy. 2: 164-171. PMID 15062139 DOI: 10.1016/S1538-4721(03)00133-8 |
0.31 |
|
2003 |
Steinvorth S, Welzel G, Fuss M, Debus J, Wildermuth S, Wannenmacher M, Wenz F. Neuropsychological outcome after fractionated stereotactic radiotherapy (FSRT) for base of skull meningiomas: a prospective 1-year follow-up. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 69: 177-82. PMID 14643955 DOI: 10.1016/S0167-8140(03)00204-4 |
0.34 |
|
2003 |
Schulz-Ertner D, Nikoghosyan A, Thilmann C, Haberer T, Jäkel O, Karger C, Scholz M, Kraft G, Wannenmacher M, Debus J. Carbon ion radiotherapy for chordomas and low-grade chondrosarcomas of the skull base. Results in 67 patients. Strahlentherapie Und Onkologie : Organ Der Deutschen RöNtgengesellschaft ... [Et Al]. 179: 598-605. PMID 14628125 DOI: 10.1007/S00066-003-1120-2 |
0.314 |
|
2003 |
Plathow C, Schulz-Ertner D, Thilman C, Zuna I, Lichy M, Weber MA, Schlemmer HP, Wannenmacher M, Debus J. Fractionated stereotactic radiotherapy in low-grade astrocytomas: long-term outcome and prognostic factors. International Journal of Radiation Oncology Biology Physics. 57: 996-1003. PMID 14575830 DOI: 10.1016/S0360-3016(03)00738-7 |
0.421 |
|
2003 |
Thilmann C, Zabel A, Milker-Zabel S, Schlegel W, Wannenmacher M, Debus J. Number and orientation of beams in inversely planned intensity-modulated radiotherapy of the female breast and the parasternal lymph nodes. American Journal of Clinical Oncology. 26. PMID 14528088 DOI: 10.1097/01.Coc.0000091354.75297.42 |
0.382 |
|
2003 |
Hof H, Herfarth KK, Münter M, Essig M, Wannenmacher M, Debus J. The use of the multislice CT for the determination of respiratory lung tumor movement in stereotactic single-dose irradiation. Strahlentherapie Und Onkologie. 179: 542-547. PMID 14509953 DOI: 10.1007/S00066-003-1070-8 |
0.358 |
|
2003 |
Münter MW, Nill S, Thilmann C, Hof H, Höss A, Häring P, Partridge M, Manegold C, Wannenmacher M, Debus J. Stereotactic Intensity-Modulated Radiation Therapy (IMRT) and Inverse Treatment Planning for Advanced Pleural Mesothelioma Strahlentherapie Und Onkologie. 179: 535-541. PMID 14509952 DOI: 10.1007/S00066-003-1055-7 |
0.377 |
|
2003 |
Kienle P, Koch M, Autschbach F, Benner A, Treiber M, Wannenmacher M, Doeberitz MvK, Büchler M, Herfarth C, Weitz J. Decreased Detection Rate of Disseminated Tumor Cells of Rectal Cancer Patients after Preoperative Chemoradiation: A First Step Towards a Molecular Surrogate Marker for Neoadjuvant Treatment in Colorectal Cancer Annals of Surgery. 238: 324-331. PMID 14501498 DOI: 10.1097/01.Sla.0000086547.27615.E6 |
0.357 |
|
2003 |
Herfarth KK, Hof H, Bahner ML, Lohr F, Höss A, van Kaick G, Wannenmacher M, Debus J. Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. International Journal of Radiation Oncology, Biology, Physics. 57: 444-51. PMID 12957256 DOI: 10.1016/S0360-3016(03)00586-8 |
0.32 |
|
2003 |
Bischof M, Huber P, Stoffregen C, Wannenmacher M, Weber KJ. Radiosensitization by pemetrexed of human colon carcinoma cells in different cell cycle phases. International Journal of Radiation Oncology Biology Physics. 57: 289-292. PMID 12909245 DOI: 10.1016/S0360-3016(03)00595-9 |
0.307 |
|
2003 |
van Kampen M, Eble MJ, Krempien R, Jensen K, Aydenitz B, Metzger M, Hensley F, Haufe S, Amelung F, Wallwiener D, Wannenmacher M. Influence of irradiated volume on ureteral injury after intraoperative radiation therapy: experimental study in dogs. Radiology. 228: 139-43. PMID 12750456 DOI: 10.1148/Radiol.2281011963 |
0.329 |
|
2003 |
Münter MW, Thilmann C, Hof H, Didinger B, Rhein B, Nill S, Schlegel W, Wannenmacher M, Debus J. Stereotactic intensity modulated radiation therapy and inverse treatment planning for tumors of the head and neck region: clinical implementation of the step and shoot approach and first clinical results. Radiotherapy and Oncology. 66: 313-321. PMID 12742271 DOI: 10.1016/S0167-8140(03)00021-5 |
0.473 |
|
2003 |
Schulz-Ertner D, Didinger B, Nikoghosyan A, Jäkel O, Zuna I, Wannenmacher M, Debus J. Optimization of radiation therapy for locally advanced adenoid cystic carcinomas with infiltration of the skull base using photon intensity-modulated radiation therapy (IMRT) and a carbon ion boost. Strahlentherapie Und Onkologie. 179: 345-351. PMID 12740662 DOI: 10.1007/S00066-003-1071-7 |
0.43 |
|
2003 |
Fritz P, Stoll P, Wannenmacher M, Zierhut D. Concurrent chemotherapy and radiation therapy for unresectable locally advanced carcinoma of the esophagus. Phase II study and clinical review on literature Strahlentherapie Und Onkologie. 179: 328. PMID 12740660 DOI: 10.1007/S00066-003-1038-8 |
0.349 |
|
2003 |
Schulz-Ertner D, Nikoghosyan A, Jäkel O, Haberer T, Kraft G, Scholz M, Wannenmacher M, Debus J. Feasibility and toxicity of combined photon and carbon ion radiotherapy for locally advanced adenoid cystic carcinomas. International Journal of Radiation Oncology, Biology, Physics. 56: 391-8. PMID 12738314 DOI: 10.1016/S0360-3016(02)04511-X |
0.314 |
|
2003 |
Hof H, Herfarth KK, Münter M, Hoess A, Motsch J, Wannenmacher M, Debus Jü. Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC). International Journal of Radiation Oncology Biology Physics. 56: 335-341. PMID 12738306 DOI: 10.1016/S0360-3016(02)04504-2 |
0.456 |
|
2002 |
Milker-Zabel S, Zabel A, Thilmann C, Zuna I, Hoess A, Wannenmacher M, Debus J. Results of three-dimensional stereotactically-guided radiotherapy in recurrent medulloblastoma Journal of Neuro-Oncology. 60: 227-233. PMID 12510774 DOI: 10.1023/A:1021184400053 |
0.401 |
|
2002 |
Milker-Zabel S, Zabel A, Thilmann C, Schlegel W, Wannenmacher M, Debus J. Clinical results of retreatment of vertebral bone metastases by stereotactic conformal radiotherapy and intensity-modulated radiotherapy International Journal of Radiation Oncology Biology Physics. 55: 162-167. PMID 12504049 DOI: 10.1016/S0360-3016(02)03864-6 |
0.422 |
|
2002 |
Münter MW, Debus J, Hof H, Nill S, Häring P, Bortfeld T, Wannenmacher M. Inverse treatment planning and stereotactic intensity-modulated radiation therapy (IMRT) of the tumor and lymph node levels for nasopharyngeal carcinomas. Description of treatment technique, plan comparison, and case study. Strahlentherapie Und Onkologie. 178: 517-523. PMID 12426839 DOI: 10.1007/S00066-002-0987-7 |
0.4 |
|
2002 |
Thilmann C, Zabel A, Kuhn S, Bendl R, Rhein B, Wannenmacher M, Debus J. Invers geplante intensitätsmodulierte Strahlenbehandlung bei einer Patientin mit rechtsseitigem Mammakarzinom und Trichterbrust Strahlentherapie Und Onkologie. 178: 637-643. PMID 12426675 DOI: 10.1007/S00066-002-0955-2 |
0.402 |
|
2002 |
Harms W, Krempien R, Hensley FW, Berns C, Fritz P, Wannenmacher M. 5-Year Results of Pulsed Dose Rate Brachytherapy Applied as a Boost after Breast-Conserving Therapy in Patients at High Risk for Local Recurrence from Breast Cancer Strahlentherapie Und Onkologie. 178: 607-614. PMID 12426671 DOI: 10.1007/S00066-002-0977-9 |
0.351 |
|
2002 |
Schulz-Ertner D, Frank C, Herfarth KK, Rhein B, Wannenmacher M, Debus J. Fractionated stereotactic radiotherapy for craniopharyngiomas. International Journal of Radiation Oncology Biology Physics. 54: 1114-1120. PMID 12419438 DOI: 10.1016/S0360-3016(02)03029-8 |
0.478 |
|
2002 |
Schulz-Ertner D, Haberer T, Scholz M, Thilmann C, Wenz F, Jäkel O, Kraft G, Wannenmacher M, Debus J. Acute radiation-induced toxicity of heavy ion radiotherapy delivered with intensity modulated pencil beam scanning in patients with base of skull tumors. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 64: 189-95. PMID 12242129 DOI: 10.1016/S0167-8140(02)00153-6 |
0.379 |
|
2002 |
Thilmann C, Schulz-Ertner D, Zabel A, Herfarth KK, Wannenmacher M, Debus J. Intensity-modulated radiotherapy of sacral chordoma--a case report and a comparison with stereotactic conformal radiotherapy. Acta Oncologica. 41: 395-399. PMID 12234033 DOI: 10.1080/028418602760169460 |
0.421 |
|
2002 |
Krempien RC, Schubert K, Zierhut D, Steckner MC, Treiber M, Harms W, Mende U, Latz D, Wannenmacher M, Wenz F. Open low-field magnetic resonance imaging in radiation therapy treatment planning. International Journal of Radiation Oncology Biology Physics. 53: 1350-1360. PMID 12128138 DOI: 10.1016/S0360-3016(02)02886-9 |
0.38 |
|
2002 |
Thilmann C, Zabel A, Nill S, Rhein B, Hoess A, Haering P, Milker-Zabel S, Harms W, Schlegel W, Wannenmacher M, Debus J. Intensity-modulated radiotherapy of the female breast. Medical Dosimetry. 27: 79-90. PMID 12074472 DOI: 10.1016/S0958-3947(02)00089-4 |
0.353 |
|
2002 |
Zabel A, Milker-Zabel S, Thilmann C, Zuna I, Rhein B, Wannenmacher M, Debus J. Treatment of brain metastases in patients with non-small cell lung cancer (NSCLC) by stereotactic linac-based radiosurgery: prognostic factors Lung Cancer. 37: 87-94. PMID 12057872 DOI: 10.1016/S0169-5002(02)00030-2 |
0.382 |
|
2002 |
Zabel A, Thilmann C, Milker-Zabel S, Schlegel W, Zuna I, Wannenmacher M, Debus J. The role of stereotactically guided conformal radiotherapy for local tumor control of esthesioneuroblastoma. Strahlentherapie Und Onkologie. 178: 187-191. PMID 12040755 DOI: 10.1007/S00066-002-0894-Y |
0.423 |
|
2002 |
Schulz-Ertner D, Haberer T, Jäkel O, Thilmann C, Krämer M, Enghardt W, Kraft G, Wannenmacher M, Debus J. Radiotherapy for chordomas and low-grade chondrosarcomas of the skull base with carbon ions. International Journal of Radiation Oncology Biology Physics. 53: 36-42. PMID 12007939 DOI: 10.1016/S0360-3016(01)02827-9 |
0.425 |
|
2002 |
Thilmann C, Grosser KH, Rhein B, Zabel A, Wannenmacher M, Debus J. Virtueller Bolus zur inversen Bestrahlungsplanung bei intensitätsmodulierter Radiotherapie des Mammakarzinoms im Rahmen der adjuvanten Therapie Strahlentherapie Und Onkologie. 178: 139-146. PMID 11962190 DOI: 10.1007/S00066-002-0915-X |
0.349 |
|
2002 |
Bischof M, Weber KJ, Blatter J, Wannenmacher M, Latz D. Interaction of pemetrexed disodium (ALIMTA, multitargeted antifolate) and irradiation in vitro. International Journal of Radiation Oncology, Biology, Physics. 52: 1381-8. PMID 11955753 DOI: 10.1016/S0360-3016(01)02794-8 |
0.348 |
|
2002 |
Schulz-Ertner D, Zierhut D, Mende U, Harms W, Branitzki P, Wannenmacher M. The role of radiation therapy in the management of desmoid tumors. Strahlentherapie Und Onkologie. 178: 78-83. PMID 11942041 DOI: 10.1007/S00066-002-0900-4 |
0.459 |
|
2002 |
Debus J, Zierhut D, Didinger B, Schlegel W, Wannenmacher M. Inverse Planning and Intensity-Modulated Radiotherapy in Patients with Prostate Cancer Frontiers of Radiation Therapy and Oncology. 36: 25-34. PMID 11842752 DOI: 10.1159/000061325 |
0.362 |
|
2001 |
Frank C, Zierhut D, Schulz-Ertner D, Wannenmacher M. Centroblastic-centrocytic non-Hodgkin's lymphoma stage I-III: patterns of failure following radiotherapy. Strahlentherapie Und Onkologie. 177: 597-603. PMID 11757182 DOI: 10.1007/Pl00002370 |
0.34 |
|
2001 |
Rudat V, Stadler P, Becker A, Vanselow B, Dietz A, Wannenmacher M, Molls M, Dunst J, Feldmann HJ. Predictive value of the tumor oxygenation by means of pO2 histography in patients with advanced head and neck cancer. Strahlentherapie Und Onkologie. 177: 462-468. PMID 11591019 DOI: 10.1007/Pl00002427 |
0.34 |
|
2001 |
Fuss M, Wenz F, Essig M, Muenter M, Debus J, Herman TS, Wannenmacher M. Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 51: 478-82. PMID 11567824 DOI: 10.1016/S0360-3016(01)01691-1 |
0.407 |
|
2001 |
Milker-Zabel S, Debus J, Thilmann C, Schlegel W, Wannenmacher M. Fractionated stereotactically guided radiotherapy and radiosurgery in the treatment of functional and nonfunctional adenomas of the pituitary gland. International Journal of Radiation Oncology Biology Physics. 50: 1279-1286. PMID 11483339 DOI: 10.1016/S0360-3016(01)01535-8 |
0.469 |
|
2001 |
Debus J, Wuendrich M, Pirzkall A, Hoess A, Schlegel W, Zuna I, Engenhart-Cabillic R, Wannenmacher M. High Efficacy of Fractionated Stereotactic Radiotherapy of Large Base-of-Skull Meningiomas: Long-Term Results Journal of Clinical Oncology. 19: 3547-3553. PMID 11481362 DOI: 10.1200/Jco.2001.19.15.3547 |
0.462 |
|
2001 |
Plathow C, Thilmann C, Delorme S, Stippich C, Wannenmacher M, Debus J. Bestrahlungsplanung rückenmarksnaher Tumoren unter Zuhilfenahme der CT-Myelographie Strahlentherapie Und Onkologie. 177: 307-312. PMID 11446320 DOI: 10.1007/Pl00002413 |
0.355 |
|
2001 |
Huber PE, Debus J, Latz D, Zierhut D, Bischof M, Wannenmacher M, Engenhart-Cabillic R. Radiotherapy for advanced adenoid cystic carcinoma: neutrons, photons or mixed beam? Radiotherapy and Oncology. 59: 161-167. PMID 11325445 DOI: 10.1016/S0167-8140(00)00273-5 |
0.437 |
|
2001 |
Rudat V, Wannenmacher M. Role of multimodal treatment in oropharynx, larynx, and hypopharynx cancer Seminars in Surgical Oncology. 20: 66-74. PMID 11291134 DOI: 10.1002/Ssu.1018 |
0.419 |
|
2001 |
Harms W, Becker HD, Krempien R, Wannenmacher M. Contemporary role of modern brachytherapy techniques in the management of malignant thoracic tumors. Seminars in Surgical Oncology. 20: 57-65. PMID 11291133 DOI: 10.1002/Ssu.1017 |
0.476 |
|
2001 |
Lehnert T, Treiber M, Tiefenbacher U, Herfarth C, Wannenmacher M. Intraoperative radiotherapy for gastrointestinal cancer Seminars in Surgical Oncology. 20: 40-49. PMID 11291131 DOI: 10.1002/Ssu.1015 |
0.384 |
|
2001 |
Harms W, Krempien R, Hensley FW, Berns C, Wannenmacher M, Fritz P. Results of chest wall reirradiation using pulsed-dose-rate (PDR) brachytherapy molds for breast cancer local recurrences. International Journal of Radiation Oncology Biology Physics. 49: 205-210. PMID 11163516 DOI: 10.1016/S0360-3016(00)01360-2 |
0.455 |
|
2000 |
Wenz F, Steinvorth S, Lohr F, Fruehauf S, Wildermuth S, Kampen Mv, Wannenmacher M. Prospective evaluation of delayed central nervous system (CNS) toxicity of hyperfractionated total body irradiation (TBI). International Journal of Radiation Oncology Biology Physics. 48: 1497-1501. PMID 11121654 DOI: 10.1016/S0360-3016(00)00764-1 |
0.31 |
|
2000 |
Fuss M, Debus J, Lohr F, Huber P, Rhein B, Engenhart-Cabillic R, Wannenmacher M. Conventionally fractionated stereotactic radiotherapy (FSRT) for acoustic neuromas. International Journal of Radiation Oncology, Biology, Physics. 48: 1381-7. PMID 11121637 DOI: 10.1016/S0360-3016(00)01361-4 |
0.37 |
|
2000 |
Pirzkall A, Lohr F, Rhein B, Höss A, Schlegel W, Wannenmacher M, Debus J. Conformal radiotherapy of challenging paraspinal tumors using a multiple arc segment technique. International Journal of Radiation Oncology Biology Physics. 48: 1197-1204. PMID 11072179 DOI: 10.1016/S0360-3016(00)00739-2 |
0.365 |
|
2000 |
Dietz A, Rudat V, Conradt C, Vanselow B, Wollensack P, Staar S, Eckel H, Volling P, Schröder M, Wannenmacher M, Müller RP, Weidauer A. Prognostic significance of initial hemoglobin in head and neck cancer treated by primary chemoradiation Hno. 48: 655-664. PMID 11056853 DOI: 10.1007/S001060050635 |
0.377 |
|
2000 |
Schulz-Ertner D, Debus J, Lohr F, Frank C, Höss A, Wannenmacher M. Fractionated stereotactic conformal radiation therapy of brain stem gliomas: outcome and prognostic factors. Radiotherapy and Oncology. 57: 215-223. PMID 11054526 DOI: 10.1016/S0167-8140(00)00230-9 |
0.45 |
|
2000 |
Lohr F, Pirzkall A, Debus J, Rhein B, Höss A, Schlegel W, Wannenmacher M. Conformal three-dimensional photon radiotherapy for paranasal sinus tumors Radiotherapy and Oncology. 56: 227-231. PMID 10927142 DOI: 10.1016/S0167-8140(00)00212-7 |
0.351 |
|
2000 |
Fuss M, Wenz F, Scholdei R, Essig M, Debus J, Knopp MV, Wannenmacher M. Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence. International Journal of Radiation Oncology, Biology, Physics. 48: 53-8. PMID 10924971 DOI: 10.1016/S0360-3016(00)00590-3 |
0.396 |
|
2000 |
Debus J, Schulz-Ertner D, Schad L, Essig M, Rhein B, Thillmann CO, Wannenmacher M. Stereotactic fractionated radiotherapy for chordomas and chondrosarcomas of the skull base. International Journal of Radiation Oncology Biology Physics. 47: 591-596. PMID 10837940 DOI: 10.1016/S0360-3016(00)00464-8 |
0.483 |
|
2000 |
Harms W, Schraube P, Becker H, Latz D, Herth F, Fritz P, Wannenmacher M. Effect and toxicity of endoluminal high-dose-rate (HDR) brachytherapy in centrally located tumors of the upper respiratory tract. Strahlentherapie Und Onkologie. 176: 60-66. PMID 10697652 DOI: 10.1007/Pl00002329 |
0.383 |
|
2000 |
Bellmann C, Fuss M, Holz FG, Debus J, Rohrschneider K, Völcker HE, Wannenmacher M. Stereotactic radiation therapy for malignant choroidal tumors: Preliminary, short-term results Ophthalmology. 107: 358-365. PMID 10690839 DOI: 10.1016/S0161-6420(99)00081-0 |
0.487 |
|
2000 |
Peper M, Steinvorth S, Schraube P, Fruehauf S, Haas R, Kimmig BN, Lohr F, Wenz F, Wannenmacher M. Neurobehavioral toxicity of total body irradiation: A follow-up in long-term survivors International Journal of Radiation Oncology Biology Physics. 46: 303-311. PMID 10661336 DOI: 10.1016/S0360-3016(99)00442-3 |
0.343 |
|
2000 |
Harms W, Latz D, Becker H, Gagel B, Herth F, Wannenmacher M. Treatment of Primary Tracheal Carcinoma The Role of External and Endoluminal Radiotherapy Strahlentherapie Und Onkologie. 176: 22-27. PMID 10650832 DOI: 10.1007/Pl00002300 |
0.376 |
|
2000 |
Feldmann HJ, Rudat V, Becker A, Stadler P, Dunst J, Wannenmacher M, Molls M. Prognostic impact of the pretreatment pO2-histography in advanced head and neck cancer patients treated with primary radio- or radiochemotherapy International Journal of Radiation Oncology Biology Physics. 48: 264. DOI: 10.1016/S0360-3016(00)80326-0 |
0.336 |
|
1999 |
Debus J, Kocag̈onc̈u KO, Ḧoss A, Wenz F, Wannenmacher M. Fractionated stereotactic radiotherapy (FSRT) for optic glioma. International Journal of Radiation Oncology Biology Physics. 44: 243-248. PMID 10760415 DOI: 10.1016/S0360-3016(98)00559-8 |
0.475 |
|
1999 |
Rudat V, Dietz A, Schramm O, Conradt C, Maier H, Flentje M, Wannenmacher M. Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy Radiotherapy and Oncology. 53: 119-125. PMID 10665788 DOI: 10.1016/S0167-8140(99)00119-X |
0.403 |
|
1999 |
Rudat V, Dietz A, Nollert J, Conradt C, Weber KJ, Flentje M, Wannenmacher M. Acute and late toxicity, tumour control and intrinsic radiosensitivity of primary fibroblasts in vitro of patients with advanced head and neck cancer after concomitant boost radiochemotherapy Radiotherapy and Oncology. 53: 233-245. PMID 10660204 DOI: 10.1016/S0167-8140(99)00149-8 |
0.445 |
|
1999 |
Bischof M, Kampen MV, Huber P, Wannenmacher M. Merkel cell carcinoma: the role of radiation therapy in general management. Strahlentherapie Und Onkologie. 175: 611-615. PMID 10633788 DOI: 10.1007/S000660050049 |
0.407 |
|
1999 |
Harms W, Latz D, Becker H, Herth F, Schraube P, Krempien R, Wannenmacher M. HDR-brachytherapy boost for residual tumour after external beam radiotherapy in patients with tracheal malignancies. Radiotherapy and Oncology. 52: 251-255. PMID 10580872 DOI: 10.1016/S0167-8140(99)00103-6 |
0.442 |
|
1999 |
Lohr F, Debus J, Frank C, Herfarth K, Pastyr O, Rhein B, Bahner ML, Schlegel W, Wannenmacher M. Noninvasive patient fixation for extracranial stereotactic radiotherapy. International Journal of Radiation Oncology Biology Physics. 45: 521-527. PMID 10487580 DOI: 10.1016/S0360-3016(99)00190-X |
0.338 |
|
1999 |
Debus J, Engenhart-Cabillic R, Kraft G, Wannenmacher M. The role of high-LET radiotherapy compared to conformal photon radiotherapy in adenoid cystic carcinoma. Strahlentherapie Und Onkologie. 175: 63-65. PMID 10394400 DOI: 10.1007/Bf03038891 |
0.434 |
|
1999 |
Krempien R, Schubert K, Latz D, Wenz F, Wannenmacher M. [MRI simulation of bronchogenic carcinomas using an open low-field MRI]. Strahlentherapie Und Onkologie : Organ Der Deutschen RöNtgengesellschaft ... [Et Al]. 175: 279-83; discussion 2. PMID 10392169 DOI: 10.1007/Bf02743579 |
0.325 |
|
1999 |
Huber P, Peschke P, Brix G, Hahn EW, Lorenz A, Tiefenbacher U, Wannenmacher M, Debus J. Synergistic interaction of ultrasonic shock waves and hyperthermia in the dunning prostate tumor r3327-at1 International Journal of Cancer. 82: 84-91. PMID 10360825 DOI: 10.1002/(Sici)1097-0215(19990702)82:1<84::Aid-Ijc15>3.0.Co;2-N |
0.328 |
|
1999 |
Debus J, Pirzkall A, Schlegel W, Wannenmacher M. [Stereotactic one-time irradiation (radiosurgery). The methods, indications and results]. Strahlentherapie Und Onkologie. 175: 47-56. PMID 10065138 DOI: 10.1007/Bf02753842 |
0.475 |
|
1998 |
Eble MJ, Lehnert T, Treiber M, Latz D, Herfarth C, Wannenmacher M. Moderate dose intraoperative and external beam radiotherapy for locally recurrent rectal carcinoma Radiotherapy and Oncology. 49: 169-174. PMID 10052883 DOI: 10.1016/S0167-8140(98)00124-8 |
0.454 |
|
1998 |
Wenz F, Steinvorth S, Wildermuth S, Lohr F, Fuss M, Debus J, Essig M, Hacke W, Wannenmacher M. Assessment of neuropsychological changes in patients with arteriovenous malformation (AVM) after radiosurgery International Journal of Radiation Oncology Biology Physics. 42: 995-999. PMID 9869221 DOI: 10.1016/S0360-3016(98)00284-3 |
0.324 |
|
1998 |
Lohr F, Wenz F, Schraube P, Flentje M, Haas R, Zierhut D, Fehrentz D, Hunstein W, Wannenmacher M. Lethal pulmonary toxicity after autologous bone marrow transplantation/peripheral blood stem cell transplantation for hematological malignancies. Radiotherapy and Oncology. 48: 45-51. PMID 9756171 DOI: 10.1016/S0167-8140(98)00045-0 |
0.373 |
|
1998 |
Latz D, Fleckenstein K, Eble M, Blatter J, Wannenmacher M, Weber KJ. Radiosensitizing potential of gemcitabine (2',2'-difluoro-2'-deoxycytidine) within the cell cycle in vitro. International Journal of Radiation Oncology, Biology, Physics. 41: 875-82. PMID 9652852 DOI: 10.1016/S0360-3016(98)00105-9 |
0.324 |
|
1998 |
Debus J, Fuß M, Engenhart-Cabillic R, Holz F, Pastyr O, Rhein B, Bortfeld T, Wannenmacher M. Stereotactic radiotherapy of choroidal metastases Ophthalmologe. 95: 163-167. PMID 9578694 DOI: 10.1007/S003470050256 |
0.418 |
|
1998 |
Peschke P, Hahn EW, Wenz F, Lohr F, Braunschweig F, Wolber G, Zuna I, Wannenmacher M. Differential Sensitivity of Three Sublines of the Rat Dunning Prostate Tumor System R3327 to Radiation and/or Local Tumor Hyperthermia Radiation Research. 150: 423-430. DOI: 10.2307/3579661 |
0.353 |
|
1997 |
Zierhut D, Lohr F, Schraube P, Huber P, Wenz F, Haas R, Fehrentz D, Flentje M, Hunstein W, Wannenmacher M. Cataract incidence after total-body irradiation. International Journal of Radiation Oncology Biology Physics. 46: 131-135. PMID 10656384 DOI: 10.1016/S0360-3016(99)00354-5 |
0.387 |
|
1997 |
Fritz P, Berns C, Anton H, Hensley F, Assman J, Flentje M, Fournier Dv, Wannenmacher M. PDR brachytherapy with flexible implants for interstitial boost after breast-conserving surgery and external beam radiation therapy. Radiotherapy and Oncology. 45: 23-32. PMID 9364628 DOI: 10.1016/S0167-8140(97)00145-X |
0.418 |
|
1997 |
Eble MJ, Wallwiener D, Junkermann H, Schmid H, Solomayer E-, Grischke EM, Wannenmacher M, Bastert G. Tumor debulking and IORT for recurrent gynecological carcinomas of the pelvic sidewall. Frontiers of Radiation Therapy and Oncology. 31: 263-266. PMID 9263838 DOI: 10.1159/000061189 |
0.35 |
|
1997 |
Eble MJ, Treiber M, Lehnert T, Herfarth C, Wannenmacher M. IORT for Recurrent Rectal Carcinoma Frontiers of Radiation Therapy and Oncology. 31: 229-233. PMID 9263829 DOI: 10.1159/000061176 |
0.304 |
|
1997 |
Eble MJ, Lehnert T, Herfarth C, Wannenmacher M. IORT as Adjuvant Treatment in Primary Rectal Carcinomas: Multi-Modality Treatment Frontiers of Radiation Therapy and Oncology. 31: 200-203. PMID 9263822 DOI: 10.1159/000061164 |
0.317 |
|
1997 |
Debus J, Engenhart-Cabillic R, Holz EG, Pastyr O, Rhein B, Bortfeld T, Wannenmacher M. Stereotactic Precision Radiotherapy in the Treatment of Intraocular Malignancies with a Micro-Multileaf Collimator Frontiers of Radiation Therapy and Oncology. 30: 39-46. PMID 9205883 DOI: 10.1159/000425686 |
0.36 |
|
1997 |
Berns C, Fritz P, Hensley FW, Wannenmacher M. Consequences of optimization in PDR brachytherapy--is a routine geometrical optimization recommendable? International Journal of Radiation Oncology Biology Physics. 37: 1171-1180. PMID 9169828 DOI: 10.1016/S0360-3016(97)00107-7 |
0.331 |
|
1997 |
Wenz F, Lohr F, Flentje M, Rudat V, Dietz A, Wannenmacher M. Predictive value of the flow cytometric PCNA assay (proliferating cell nuclear antigen) in head and neck tumors after accelerated-hyperfractionated radiochemotherapy International Journal of Radiation Oncology Biology Physics. 37: 771-776. PMID 9128950 DOI: 10.1016/S0360-3016(97)00024-2 |
0.41 |
|
1996 |
Fritz P, Hensley FW, Berns C, Schraube P, Wannenmacher M. First experiences with superfractionated skin irradiations using large afterloading molds. International Journal of Radiation Oncology Biology Physics. 36: 147-157. PMID 8823270 DOI: 10.1016/S0360-3016(96)00283-0 |
0.365 |
|
1996 |
Rudat V, Schraube P, Oetzel D, Zierhut D, Flentje M, Wannenmacher M. Combined error of patient positioning variability and prostate motion uncertainty in 3D conformal radiotherapy of localized prostate cancer. International Journal of Radiation Oncology Biology Physics. 35: 1027-1034. PMID 8751412 DOI: 10.1016/0360-3016(96)00204-0 |
0.329 |
|
1996 |
Aβmann J, Fritz P, Brambs H-, Wannenmacher M. 150 Combined modality treatment of carcinomas of the bile duct with intraluminal HDR-after-loading and external irradiation Radiotherapy and Oncology. 39. DOI: 10.1016/0167-8140(96)87954-0 |
0.318 |
|
1995 |
Goldschmidt H, Hegenbart U, Moos M, Eugenhart R, Haas R, Hunstein W, Wannenmacher M. Sequential high‐dose treatment with peripheral blood progenitor cell transplantation in patients with multiple myeloma Stem Cells. 13: 36-41. PMID 8747987 DOI: 10.1002/Stem.5530130707 |
0.371 |
|
1995 |
Haas R, Murea S, Goldschmidt H, Döhner H, Moos M, Witt B, Hunstein W, Eugenhart R, Wannenmacher M. High‐dose therapy with peripheral blood progenitor cell support in patients with non‐hodgkin's lymphoma Stem Cells. 13: 28-35. PMID 8747986 DOI: 10.1002/Stem.5530130706 |
0.362 |
|
1995 |
Zierhut D, Flentje M, Adolph J, Erdmann J, Raue F, Wannenmacher M. External radiotherapy of pituitary adenomas International Journal of Radiation Oncology Biology Physics. 33: 307-314. PMID 7673017 DOI: 10.1016/0360-3016(95)00071-6 |
0.462 |
|
1995 |
Haas R, Witt B, Mohle R, Goldschmidt H, Hohaus S, Freuhauf S, Wannenmacher M, Hunstein W. Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell support. Blood. 85: 3754-3761. DOI: 10.1182/Blood.V85.12.3754.Bloodjournal85123754 |
0.375 |
|
1995 |
Schraube P, Latz D, Wannenmacher M. Treatment of primary squamous cell carcinoma of the trachea: The role of radiation therapy Medical Dosimetry. 20: 144. DOI: 10.1016/0958-3947(94)01484-6 |
0.364 |
|
1994 |
Fritz P, Brambs H, Schraube P, Freund U, Berns C, Wannenmacher M. Combined external beam radiotherapy and intraluminal high dose rate brachytherapy on bile duct carcinomas International Journal of Radiation Oncology Biology Physics. 29: 855-861. PMID 8040034 DOI: 10.1016/0360-3016(94)90576-2 |
0.471 |
|
1994 |
Engenhart R, Wowra B, Debus J, Kimmig BN, Höver K, Lorenz W, Wannenmacher M. The role of high-dose, single-fraction irradiation in small and large intracranial arteriovenous malformations☆ International Journal of Radiation Oncology Biology Physics. 30: 521-529. PMID 7928482 DOI: 10.1016/0360-3016(92)90937-D |
0.438 |
|
1994 |
Schraube P, Latz D, Wannenmacher M. Treatment of primary squamous cell carcinoma of the trachea: the role of radiation therapy Radiotherapy and Oncology. 33: 254-258. PMID 7716265 DOI: 10.1016/0167-8140(94)90360-3 |
0.419 |
|
1994 |
Haas R, Mohle R, Fruhauf S, Goldschmidt H, Witt B, Flentje M, Wannenmacher M, Hunstein W. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood. 83: 3787-3794. DOI: 10.1182/Blood.V83.12.3787.Bloodjournal83123787 |
0.363 |
|
1993 |
Flentje M, Hensley F, Gademann G, Menke M, Wannenmacher M. Renal tolerance to nonhomogenous irradiation: comparison of observed effects to predictions of normal tissue complication probability from different biophysical models. International Journal of Radiation Oncology, Biology, Physics. 27: 25-30. PMID 8365942 DOI: 10.1016/0360-3016(93)90417-T |
0.373 |
|
1992 |
Müller-Schimpfle M, Layer G, Köster A, Brix G, Kimmig B, Kauczor HU, Wannenmacher M, Semmler W, Kaick GV. MRI and MRA in treatment planning of subdiaphragmatic radiation therapy Journal of Computer Assisted Tomography. 16: 110-111. PMID 1729289 DOI: 10.1097/00004728-199201000-00021 |
0.305 |
|
1992 |
Dietl B, Kauczor HU, Brix G, Semmler W, Kaick Gv, Wannenmacher M. Late bone marrow changes in Hodgkin's disease patients: a characterization with proton chemical shift imaging European Radiology. 2: 204-208. DOI: 10.1007/Bf00595831 |
0.367 |
|
1991 |
Hodapp N, Boesecke R, Schlegel W, Bruggmoser G, Wannenmacher M. Three-dimensional treatment planning for conformation therapy of a bronchial carcinoma Radiotherapy and Oncology. 20: 245-249. PMID 2068342 DOI: 10.1016/0167-8140(91)90123-X |
0.37 |
|
1990 |
Engenhart R, Kimmig BN, Höver K, Wowra B, Sturm V, Kaick GV, Wannenmacher M. Stereotactic single high dose radiation therapy of benign intracranial meningiomas. International Journal of Radiation Oncology Biology Physics. 19: 1021-1026. PMID 2120162 DOI: 10.1016/0360-3016(90)90028-I |
0.48 |
|
1982 |
Slanina J, Wannenmacher M, Kuphal K, Knufermann H, Beck C, Schilli W. Interstitial radiotherapy with 198AU seeds in the primary management of carcinoma of the oral tongue: Results in freiburg/breisgau from January 1964 to July 1980 International Journal of Radiation Oncology Biology Physics. 8: 1683-1689. PMID 7153078 DOI: 10.1016/0360-3016(82)90287-5 |
0.357 |
|
Show low-probability matches. |